Pregnancy with Metastatic Gastrointestinal Stromal Tumor (GIST) on Imatinib Chemotherapy: an Oncologist’s Nightmare and Obstetrician’s Dilemma
- First Online:
- 209 Downloads
Gastrointestinal stromal tumors (GISTs) are among the few cancers amenable to successful treatment by targeted molecular therapy with KIT receptor inhibitors like imatinib mesylate. Increasing incidence of this tumor and its successful treatment has given rise to issues of fertility and child bearing in patients affected at young age. Although contraception advice and termination of early pregnancy have been the standard practice in patients on such therapy, an occasional patient who desires pregnancy can leave both obstetrician and oncologist perplexed.
We report our experience in a rare patient of metastatic GIST who had a successful normal pregnancy while on imatinib therapy. We further attempt to evaluate similar evidence in literature.
KeywordsMetastatic gastrointestinal stromal tumor Pregnancy Imatinib Cancer chemotherapy
- 2.Demetri GD. Gastrointestinal stromal tumors. In: De Vita Jr VT, Lawrence TS, Rosenberg SA, editors. Cancer principles and practice of oncology. 9th ed. Philadelphia: Wolters Kluwer/Lippincott Williams and Wilkin; 2011. p. 1060–73.Google Scholar
- 4.Coveney SD. Twin pregnancy complicated by an adnexal mass. AJUM. 2011;14(1):31–3.Google Scholar
- 5.Stubbs BM, Desai A, Singh S, Seddon B, Khan F. Gastrointestinal stromal tumour in pregnancy. BMJ Case Rep 2011; pii: bcr0120113737. doi: 10.1136/bcr.01.2011.3737
- 6.Scherjon S, Lam WF, Gelderblom H, Jansen FW. Gastrointestinal stromal tumor in pregnancy: a case report. Case Report Med. 2009; doi:10.1155/2009/456402, PMCID: PMC2745024].
- 7.Lanzafame S, Minutolo V, Caltabiano R, Minutolo O, Marino B, Gagliano G, et al. About a case of GIST occurring during pregnancy with immunohistochemical expression of epidermal growth factor receptor and progesterone receptor. Pathol Res Pract. 2006;202(2):119–23. Epub 2006 Jan 18. PMID:16413690.PubMedCrossRefGoogle Scholar
- 8.Nilsson B, Bumming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the pre imatinib mesylate era—a population based study in western Sweden. Cancer. 2005;103:821–9. PMID:15648083.PubMedCrossRefGoogle Scholar